Offered Price $48.00

DeVry NR505 Week 1 TII Draft Latest 2017 January

Question # 00489749
Subject: General Questions
Due on: 02/24/2017
Posted On: 02/24/2017 12:09 AM

Expert tutors with experiences and qualities
Posted By
Best Tutors for school students, college students
Feedback Score:

Purchase it
Report this Question as Inappropriate

Clinical Practice Guideline Summary Template

Using this worksheet which is based on the AGREE II instrument, evaluate your clinical practice guideline using these questions:

Domain I: Score and Purpose

· What is the overall objective of the guideline? What is the scope and purpose of this CPG?

· What health question(s) are covered by the guideline? Be specific.

· Who is the target population (patients, public, consumers, students, etc.) to whom the guideline is meant to apply? Who are the recipients of the services outlined in the document?

Domain 2: Stakeholder Involvement

· What professions are represented in the guideline development group?

· How well were the target populations’ views and preferences considered and sought?

Domain 3: Rigor of Development

· What systematic methods were used to search for evidence to develop the CPG?

· What were the criteria for selecting the evidence?

· What are the strengths and limitations of the body of evidence used to develop the CPG?

· How were health benefits, side effects, and risks considered in developing the CPG?

· What explicit link is present between the recommendations and the supporting evidence?

· How was the CPG externally reviewed by experts prior to its publication?

· What procedure is in place for updating the CPG?

Domain 4: Clarity and presentation

· What key recommendations are presented? How specific and unambiguous are the recommendations? How easily identifiable where these recommendations?

· What are the different options for managing the condition or health issue presented in the CPG? How clearly are they presented in the CPG?

Domain 5: Applicability

· What facilitators and barriers to the application of the CPG?

· How did the CPG provide advice and/or tools on the application of the recommendation into practice?

· What potential resource implications of applying the recommendations have been considered?

· What key monitoring and/or auditing criteria are presented in the CPG?

Domain 6: Editorial independence

· How ere the views of the funding body kept from influencing the content of the guideline?

· What conflicts of interest are possible?

· How are the competing interests of the CPG group members recorded and addressed?


· Does the CPG answer the key clinical questions presented in the CPG?

· How will you, as the advanced practice nurse, apply this CPG in practice?

Tags 0 january latest draft nr505 week devry guideline presented practice recommendations cpgdomain considered evidence develop target specific criteria used apply development group application views andor questions whatare purpose health whatkey body clinical updating clarity clearly applicability place

Tutorials for this Question
Available for

DeVry NR505 Week 1 TII Draft Latest 2017 January

Tutorial # 00486191
Posted On: 02/24/2017 12:10 AM
Posted By:
Best Tutors for school students, college students katetutor
Expert tutors with experiences and qualities
Feedback Score:
Report this Tutorial as Inappropriate
Tutorial Preview …Latest xxxx JanuaryDeVry…
Week_1_TII_Draft.doc (51 KB)
Preview: supports xxxx the xxx of the xxxxxxx soap can xx of xxxxxxxxxx xxx the xxxxxxxxx of SSI xxxxxx the surgical xxxxxxxxx is xxxxxxxxxx xxxxxxxxxx the xxxx of information xx the patient xxxxxxxxx the xxxx xxxxxx for xxx reduction of xxx cases Specifically, xxx infection xxxx xxx the xxxxxxx days after x surgery near xxx surgical xxxxx xx a xxxxxxxxxxxx factor to xxx rise in xxx number xx xxxxxxxxxxx as xxxx as the xxxxxxxx in yearly xxxxxxxxx rates xxxxxxx xxx Luke, xxxxx Considerably, have xxxx measures used xxx the xxxxxxxxx xx infections xx surgical sites xx proposed by xxxxxx and xxxx xxxxxxx the xxxxx include the xxxxxx application of xx antibiotics, xxx xxx of xxxxxxxxxx that are xxxxxxxxxxx to an xxxxxxxxxx the xxx xx neutralizing xxxxxx for the xxxxxxxxxxxxxx of the xxxxxx or xxx xxxxxxxxxxxxx on xxx surgical site xxxxxxxx Webster and xxxxxxx (2015) xxxxxxx xxxx since xxx primary cause xx surgical sites xxxxxxxxxx is x xxxxxx of xxxxxxxxxxxxxx it is xxxxxxxxxxx for the xxxxxxxx methods xx xx used xxxx as the xxxxxxxxxxxxx soap during xxx bathing xx xxxxxxxx before xxxxxxxx procedures Typically, xxxx is a xxxx expensive xxx xxx can xx used in xxxxxxxxxxxx numerous methods xxxx as xxx xxxxx of xxxxxxxxxxx as a xxxxxx of infections xx the xxxxxxxx xxxx and xxx rise in xxx rate of xxxxxxxx bills xxxxxxxxxxx xxxxxxxxxxx The xxxxx shareholders of xxx project are xxx World xxxxxx xxxxxxxxxxxx (WHO) xxx organization took xxxx in the xxxxxxxx of xxx xxxxxxxxx on xxx need for xxx management of xxxxx of xxxxxxxx xxxx infections xx result of xxx increase in xxx cases xxxxx xxxxxxxx in xxx healthcare organization xxxxx Typically, the xxxx that xx xxxxxxxx in xxx investigation includes xxx surgeons, nurses, xxx other xxxxxxx xxxxxx as xxxx as any xxxxx surgical team xxxxxxx Furthermore, xxx xxxxxxxxxx and xxx staff that xx fundamental in xxx sterilization xx xxx surgical xxxxxxxxxx are the xxxxxxxxxxxx who have x critical xxxx xx the xxxxxx of the xxxxxxx from SSI xxx final xxxxxxx xx the xxxxxxxxxx are to xx implemented by xxx Infection xxxxxxxxxx xxx Control xxxxxxxxxxxxx for the xxxxxxxxxxx of efficient xxxxxx of xxxxxxxx xxx policy xx Rigor of xxxxxxxxxxx The development xx guidelines xxxx xxxx consideration xxx standards that xxx set by xxx.....
Purchase this Tutorial @ $48.00 *
* - Additional Paypal / Transaction Handling Fee (3.9% of Tutorial price + $0.30) applicable